|Articles|March 1, 2007

Safeguarding kids from environmental hazards

There is increasing evidence that environmental toxicants affect kids' health. Given this reality, pediatricians need to know the most important environmental health questions to ask, and what resources to draw from.

Newsletter

Access practical, evidence-based guidance to support better care for our youngest patients. Join our email list for the latest clinical updates.

Subscribe Now!

Related Content

Can you diagnose this 18-year-old with nausea and vomiting?

ByAbigail A. Childress, BS,Allison M. Davis, MD,Lissa X. Yu, MD

November 11th 2025

GeneDx receives FDA Breakthrough Device Designation for whole genome and exome tests

ByMorgan Ebert, Managing Editor

November 10th 2025

Dale Lee, MD, explains best practices for celiac disease follow-up

ByDale Lee, MD

November 10th 2025

Safety, tolerability of tenapanor in pediatric IBS-C patients, with Thomas Wallach, MD

ByThomas Wallach, MD

November 7th 2025

Odevixibat demonstrates sustained pruritus and bile acid improvements in FIC1 deficiency

ByJoshua Fitch, Senior Editor

November 7th 2025

Latest CME

Video

Clinical Consultations™: Addressing Elevated Phosphate Levels in Patients with END-STAGE Kidney Disease (ESKD)

Anil K. Agarwal, MD, FACP, FASN, FNKF, FASDIN; Jay B. Wish, MD

Multimedia

Advances In: Managing Hyperphosphatemia in Chronic Kidney Disease – Bridging Treatment Gaps With Novel Therapies

Glenn M. Chertow, MD, MPH; Anjay Rastogi, MD, PhD

Case-based Simulation

SimulatED™: Understanding the Role of Genetic Testing in Patient Selection for Anti-Amyloid Therapy

Nicholas Doher, DO; Babak Tousi, MD

Multimedia

Burst CME™: Addressing Inadequate Response to Anti-TNF Therapy in Patients With Rheumatoid Arthritis

Jeffrey A. Sparks, MD, MMSc

Multimedia

Community Practice Connections™: Cases and Conversations – Keeping Up with Novel Approaches to Managing ANCA-Associated Vasculitis

Frank B. Cortazar, MD; Lindsay S. Lally, MD

Video

Burst CME: Targeted Therapy for Optimal Psoriasis Management

Tina Bhutani, MD

Video

Cases and Conversations™: A Horizon View of Continuous Monitoring Systems for Diabetes Management

Diana Isaacs, PharmD, BCPS, BC-ADM, BCACP, CDCES, FADCES, FCCP; Anders Carlson, MD; Jennifer B. Green, MD

Video

Progress in Hyperlipidemia Management to Reduce ASCVD Risk: An Illustrated Update

Nihar R. Desai, MD, MPH; Martha Gulati, MD, MS, FACC, FAHA, MASPC, FESC, FSCCT (hon), FRCP Edin

Safeguarding kids from environmental hazards

Newsletter

Related Content

Can you diagnose this 18-year-old with nausea and vomiting?

GeneDx receives FDA Breakthrough Device Designation for whole genome and exome tests

Dale Lee, MD, explains best practices for celiac disease follow-up

Safety, tolerability of tenapanor in pediatric IBS-C patients, with Thomas Wallach, MD

Odevixibat demonstrates sustained pruritus and bile acid improvements in FIC1 deficiency

Latest CME

Clinical Consultations™: Addressing Elevated Phosphate Levels in Patients with END-STAGE Kidney Disease (ESKD)

Advances In: Managing Hyperphosphatemia in Chronic Kidney Disease – Bridging Treatment Gaps With Novel Therapies

SimulatED™: Understanding the Role of Genetic Testing in Patient Selection for Anti-Amyloid Therapy

Burst CME™: Addressing Inadequate Response to Anti-TNF Therapy in Patients With Rheumatoid Arthritis

Community Practice Connections™: Cases and Conversations – Keeping Up with Novel Approaches to Managing ANCA-Associated Vasculitis

Burst CME: Targeted Therapy for Optimal Psoriasis Management

Cases and Conversations™: A Horizon View of Continuous Monitoring Systems for Diabetes Management

Progress in Hyperlipidemia Management to Reduce ASCVD Risk: An Illustrated Update

Trending on Contemporary Pediatrics

GeneDx receives FDA Breakthrough Device Designation for whole genome and exome tests

Dale Lee, MD, explains best practices for celiac disease follow-up

Improved Pediatric AD Clinical Trial Design and Efficacy Outcomes

Tapinarof Efficacy and Safety in Pediatric AD Care